RNA Outsourcing Resources

  1. Mapping The Future: Q&A With Mark Sawicki, Ph.D., On 2025 Trends In CGT 2/25/2025

    Learn how you can stay ahead of the evolving cell and gene therapy landscape by leveraging innovative solutions to support the continued growth and success of therapies in 2025 and beyond.

  2. The Shift Toward Flexible FSP Models 11/13/2025

    Flexible FSP models are reshaping clinical outsourcing by offering sponsors scalable, cost-predictable partnerships that preserve control, enhance quality, and support long-term strategic goals.

  3. 6 Trends Redefining Biologics Manufacturing In 2026 5/14/2026

    Biologics manufacturing is evolving through smarter fill technologies, onshoring, advanced automation, and data driven processes that improve efficiency, reduce risk, and protect product value.

  4. The Gateway To Europe: How The Stevenage Supply Chain Hub Supports ATMP Development 3/25/2025

    Ensure seamless access to European clinical trials and markets with GMP-compliant logistics, regulatory support, and risk mitigation to protect the integrity of your advanced therapies.

  5. Using Synthetic ssDNA And dsDNA Templates For CRISPR Editing 6/19/2026

    Synthetic ssDNA and dsDNA donor templates boost CRISPR precision, efficiency, and consistency. The right strategy reduces errors, increases HDR, and delivers more reliable results across applications.

  6. Screening T7 Polymerases To Optimize xRNA Yield And Quality 10/31/2025

    Discover how the evolution of T7 polymerase is optimizing in vitro transcription for RNA therapeutics. Learn to balance performance, cost, and supply to make smart choices for your xRNA manufacturing.

  7. Time: A Crucial Factor In Therapeutics Development 4/21/2025

    Accelerate your mRNA development and strengthen your response to emerging health threats with next-generation, cell-free DNA template solutions designed for speed, quality, and reliability.

  8. New Perspectives On Accelerating Genetic Nanomedicines Through The Regulatory Pathway 3/1/2024

    Discover how regulatory bodies are adopting a risk-based approach to address the unique challenges of genetic nanomedicines, and stakeholder engagement is essential.

  9. What Is The Role Of CROs In Drug Development? 5/13/2025

    CROs are not just facilitators but strategic innovators essential for delivering new therapies to patients efficiently and safely.

  10. From LAL To rFC: The Evolution Of Endotoxin Testing 6/26/2026

    Protect patient safety and ensure regulatory compliance by implementing sensitive, reliable bacterial endotoxin testing as a critical component of pharmaceutical quality assurance.